Gosselies-based healthtech company OncoDNA has raised €19m (US$20m) Series B funding led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. “We are delighted to have successfully raised sufficient new capital from such quality investors who will enable us to grow and increase our support to oncologists and cancer patients with our data-driven solutions,”…
©2020 All rights reserved LaingBuisson 
 Series B funding led by Vesalius Biocapital III and Swisscanto Invest.){kind=link}